ClinVar Miner

Submissions for variant NM_017617.5(NOTCH1):c.433G>A (p.Ala145Thr)

dbSNP: rs1388726872
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001343127 SCV001537091 benign Adams-Oliver syndrome 5 2022-12-06 criteria provided, single submitter clinical testing
GeneDx RCV001751670 SCV001988026 uncertain significance not provided 2021-04-29 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 1039617; Landrum et al., 2016); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function
Genome-Nilou Lab RCV001343127 SCV002554012 uncertain significance Adams-Oliver syndrome 5 2022-03-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV002271223 SCV002554013 uncertain significance Aortic valve disease 1 2022-03-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV002329320 SCV002630972 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2021-10-13 criteria provided, single submitter clinical testing The p.A145T variant (also known as c.433G>A), located in coding exon 4 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 433. The alanine at codon 145 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Department of Human Genetics, Nagasaki University RCV003159076 SCV003762185 other Cholesteatoma of middle ear criteria provided, single submitter research variant allele frequency in tumor is 0.0681 (54/739)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.